The U.S. endoscopes market size is calculated at USD 5.19 billion in 2025 and is forecasted to reach around USD 11.22 billion by 2034, accelerating at a CAGR of 9.00% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Endoscopes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Endoscopes Market Revenue and Volume, by Product
8.1.1 Flexible Endoscopes
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Capsule Endoscopes
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Robot Assisted Endoscopes
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Rigid Endoscopes
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Disposable Endoscopes
8.1.5.1. Market Revenue and Volume Forecast
9.1. U.S. Endoscopes Market Revenue and Volume, by Application
9.1.1. Arthroscopy
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Urology Endoscopy
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Laparoscopy
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Gastrointestinal (GI) Endoscopy
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Bronchoscopy
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Mediastinoscopy
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Gynecology Endoscopy
9.1.7.1. Market Revenue and Volume Forecast
9.1.8. Otoscopy
9.1.8.1. Market Revenue and Volume Forecast
9.1.9. Laryngoscopy
9.1.9.1. Market Revenue and Volume Forecast
9.1.10. Others
9.1.10.1. Market Revenue and Volume Forecast
10.1. U.S. Endoscopes Market Revenue and Volume, by End-Use
10.1.1. Ambulatory Surgery Centers
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Hospitals
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast
11.1. U.S.
11.1.1. Market Revenue and Volume Forecast, by Product
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End-Use
12.1. Olympus Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Stryker Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Ethicon Endo-Surgery, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Boston Scientific
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Arthrex, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ConMed
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Medtronic
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Johnson & Johnson
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Cook Medical
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Richard Wolf GmbH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample